Case Series of Cancer Patients Treated With Galunisertib, a Transforming Growth Factor-Beta Receptor I Kinase Inhibitor in a First-in-Human Dose Study | Zendy

AI Assistant Blog Pricing

Open Access

Case Series of Cancer Patients Treated With Galunisertib, a Transforming Growth Factor-Beta Receptor I Kinase Inhibitor in a First-in-Human Dose Study

Author(s) -

Analía Azaro,

Jordi Rodón,

Michael Carducci,

Juan Manuel Sepúlveda-Sánchez,

Ivelina Gueorguieva,

Ann Cleverly,

D. Desaiah,

Sokalingum P. Namaseevayam,

Matthias Holdhoff,

Michael Lahn

Publication year - 2014

Publication title -

journal of medical cases

Language(s) - English

Resource type - Journals

eISSN - 1923-4163

pISSN - 1923-4155

DOI - 10.14740/jmc1966w

Subject(s) - medicine , adverse effect , cancer , colorectal cancer , gastroenterology , diarrhea , clinical trial , oncology

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom

About

About Careers Publisher Partners Contact Us Get Organisational Trial or Quote

Learn

FAQs Blog Terms of Use Privacy Policy

Download the Zendy App

Download on the

Discover

Explore

Copyright Knowledge E © 2026. All Rights Reserved.